A Guide To 2026 Advances In Veterinary Care For Dogs & Cats

Veterinary medicine is an evolving field, and this expert article highlights just some of the 2026 advances in veterinary care. As new diagnostic and treatment options become available, Alford Avenue Veterinary Hospital is committed to staying up-to-date and, in turn, educating pet owners on advances in care. This month, we want to highlight some of these advances.

2026 Advances In Veterinary Care: Parasites Beware

First, we’ve recently added Bravecto Quantum for dogs to our options for parasite protection. This is an injection that provides one year of protection against flea and tick infestation. See our previous blog on Flea and Tick Prevention for more information on these parasites. These parasites have a major impact on our pets. Bravecto Quantum provides us with a way to make sure dogs are protected against infestation without pet owners having to remember the regular administration or application of a preventive product.

In addition, we offer ProHeart 12: an injection that provides one year of protection against heartworm infection, and there’s real potential for synergy between these two preventives. We can now protect our dog patients from our region’s most medically significant parasites in one visit with two simple injections.

2026 Advances In Veterinary Care: A New Treatment Option For Allergies In Dogs

We’re adding Numelvi as a new weapon in the ongoing war against allergic skin disease. Numelvi inhibits a protein (JAK-1) that signals the body to become inflamed and itchy when exposed to an allergen. We’ve been using another JAK inhibitor, Apoquel, for many years—and it remains a good option for many patients—but (1) Numelvi is labeled to be given to dogs as young as 6 months of age, (2) it’s more selective in targeting JAK-1, the primary driver of itchiness, and (3) it comes in at a lower price point, making allergy relief accessible to more pets. See last month’s blog to learn more about Allergies in Pets.

2026 Advances In Veterinary Care: A Powerful New Pancreatitis Treatment

Pancreatitis is inflammation of the pancreas, and it is a dangerous condition with a mortality rate of roughly 40%. In dogs, this is often associated with sudden diet changes (purposeful or not) and risk factors like excessive fat in the blood (hypertriglyceridemia). Pancreatitis typically leads to vomiting, abdominal pain, poor appetite, and/or diarrhea but may also lead to problems with blood clotting, mineral and electrolyte abnormalities, and/or gallbladder disease. For most of our profession’s existence, we’ve only been able to provide supportive care for this condition: fluids, pain medication, and treatments for nausea and diarrhea. Panoquell-CA1 now provides us with the ability to directly treat the inflammation within the pancreas. Panoquell-CA1 has been proven safe and effective enough to gain conditional approval from the FDA while additional tests are pending. This treatment is an intravenous injection for dogs that blocks inflammatory cells from entering the pancreas, relieving symptoms and shortening hospital stays due to pancreatitis.

2026 Advances In Veterinary Care: Diagnostic Tools For Cats

Heart disease can be a silent killer in cats. For any cats with abnormal heart sounds, rate, or rhythm, we recommend an echocardiogram. A basic screening echocardiogram can be done in our clinic without having to wait on a referral or traveling for several hours with your cat to a veterinary teaching hospital. Hypertrophic cardiomyopathy (HCM) is one of the most common diagnoses we make from an echocardiogram. This is a genetic disease that causes the heart muscle to become abnormally thick, preventing the heart from efficiently relaxing to fill with blood. Over time, this condition can lead to high blood pressure, blood clots, and congestive heart failure. We now have a conditionally released medication called Felicyn-CA1. Like Panoquell-CA1, the medication has shown enough promise in that the FDA has allowed it to be sold prior to the completion of ongoing studies.

Another common disease in cats is diabetes mellitus. Traditionally, our treatment approach has involved diet modification and the use of twice daily insulin injections to regulate blood sugar. This affects everyone in the household. Day-to-day activities and vacation plans may need to be altered to accommodate a cat’s treatment schedule, to mention nothing of monitoring needs. Now, there are two oral medication options for feline diabetes: Bexacat and Senvelgo. Bexacat is a pill while Senvelgo is a liquid. Both are labeled for once daily usage and, unlike insulin, do not have to be given alongside a meal. The mode of action (SGLT-2 inhibitor) of these medications means that dangerously low blood glucose (hypoglycemia) is highly unlikely. For many, but not all newly diagnosed diabetic cats, an SGLT-2 inhibitor is a more convenient, safer—maybe better—option than insulin.

There’s one last conditionally approved product to discuss, Varenzin-CA1. Red blood cell production is often decreased in cats with aging-related chronic kidney disease. This is because the kidneys are responsible for producing erythropoietin, a hormone that stimulates the bone marrow to produce red blood cells. Deficiency in red blood cells is called anemia. Anemia leads to poor oxygenation of the body’s tissues because oxygen delivery is a red blood cell’s primary function. In the past, we’ve had to rely on direct administration of erythropoietin products which are expensive and can sometimes lead to allergic reaction. Varenzin-CA1 stabilizes the kidneys’ ability to produce their own erythropoietin, resulting in an uptick in red blood cell production and, in many cases, resolution of anemia, greatly improving the energy level and quality of life of chronic kidney disease patients.

2026 Advances In Veterinary Care: New Diagnostic Capabilities

For the last few months, we’ve been using the IDEXX inVue Cellular Analyzer for ear and blood cytology. This machine provides an objective way to evaluate ear swabs for infection and eliminates the inconsistency that may arise from different veterinarians or technicians manually reading slides under the microscope. It also can review blood samples when a complete blood count (CBC) indicates any issues in number or appearance of certain blood components. In the future, IDEXX plans to expand the inVue’s capabilities, allowing it to help us evaluate aspirates of skin tumors with feedback from a clinical pathologist, decreasing the time and expense it takes to get a diagnosis.

Looking to the Future

We’re always looking forward to advances in the care of our patients because our goal is the same as yours: to maintain the health and comfort of your pets. As our partners in research and development improve our ability to meet this goal, rest assured that we’ll continue updating our approach to veterinary medicine.

Need to deploy 2026 advances in veterinary care for your dog or cat? Schedule an appointment with Alford Avenue Veterinary Hospital in Hoover, Alabama.